Claus Juan Møller-San Pedro
Direktor/Vorstandsmitglied bei Terranol A/S
Ursprung des Netzwerks ersten Grades von Claus Juan Møller-San Pedro
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
29
| Public Company | Pharmaceuticals: Major | 29 |
| Public Company | Pharmaceuticals: Major | 15 | |
Azanta A/S
 Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Terranol A/S
 Terranol A/S Miscellaneous Commercial ServicesCommercial Services Terranol A/S develops yeasts to be applied in second generation bioethanol production. Its second generation bioethanol is produced from agricultural wastes, such as wheat straw, sugar cane bagasse, corn stover, and wood chips. It has developed industrial yeasts that converts all sugars and also the sugar xylose in biomass into ethanol. The company's technology Terranol Strain V-1 ferments glucose and xylose into ethanol with high yield and low production of the byproduct xylitol. Terranol was founded by Thomas Hvid Andersen, Birgitte Rønnow, and Ole Sibbesen in October 2007 and is headquartered in Kongens Lyngby, Denmark.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Claus Juan Møller-San Pedro
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Chairman Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| Copenhagen Business School | College/University | Undergraduate Degree Graduate Degree Graduate Degree Masters Business Admin Graduate Degree | |
| University of Aarhus | College/University | Graduate Degree Graduate Degree Doctorate Degree Graduate Degree | |
Genmab, Inc.
 Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member Chief Operating Officer Director/Board Member | |
| Princeton University | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Graduate Degree | |
| University of Utrecht | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
International N&H Denmark ApS
 International N&H Denmark ApS Food: Major DiversifiedConsumer Non-Durables DuPont Nutrition Biosciences ApS is engaged in the production of food enzymes, products and pharmaceutical grade excipients for food products. It operates through the following divisions: Enablers, BioActives, Sweeteners, Cultures, Genecor and Sales and Application Food Ingredients. The Enablers division develops, produces and markets emulsifiers, hydrocolloids, and tailored systems that enable food & beverage manufactureres to make appealing products. The BioActives division is comprised of the Cultures and Sweeteners divisions. It offers food cultures and protective solutions, speciality sweeteners, health ingredients, and microorganisms for agriculture and animal nutrition. The Genencor division develops innovative enzymes and bioproducts to reduce the environmental impact of the cleaning, textile, fuel, and chemical industries. The sales and Application food Ingredients division manages and budgets global key accounts. The company was founded in 1989 and is headquartered Copenhagen, Denmark | Food: Major Diversified | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| University of Leiden | College/University | Graduate Degree Doctorate Degree | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| Radboud University Nijmegen | College/University | Doctorate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Masters Business Admin | |
| FORWARD PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Founder | |
| VICORE PHARMA HOLDING AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
Azanta Danmark A/S
 Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Azanta Danmark A/S operates as biopharmaceutical company developing treatments for women's health indications and for orphan oncology. The firm develops protein therapeutics within oncology and infectious diseases. The company was founded by Martin N. Bonde, Jens Christian Jensenius, Steffen Thiel, and R. Alan B. Ezekowitz in 2000 and is headquartered in Valby, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Lund | College/University | Graduate Degree Graduate Degree | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Corporate Secretary Corporate Officer/Principal | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Founder | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| Bond 2 Development 2 Gp Ltd. | Director/Board Member | ||
| THE INTERPUBLIC GROUP OF COMPANIES, INC. | Advertising/Marketing Services | Corporate Officer/Principal | |
| ABM INDUSTRIES INCORPORATED | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
| MSG NETWORKS INC. | Broadcasting | Comptroller/Controller/Auditor | |
| Ascendis Pharma Oncology Division A/S | Chairman | ||
| Ascendis Pharma Ophthalmology Division A/S | Chairman | ||
| Ascendis Pharma, Inc. | Director/Board Member | ||
| International Association for the Study of Lung Cancer | Corporate Officer/Principal | ||
| Danish Society of Medical Oncology | Corporate Officer/Principal | ||
| Danish Society of Internal Medicine | Corporate Officer/Principal | ||
| SPHERE ENTERTAINMENT CO. | Media Conglomerates | Comptroller/Controller/Auditor | |
| BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Director/Board Member | |
VISEN Pharmaceuticals
 VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China. | Biotechnology | Chairman | |
| ALK-ABELLÓ A/S | Biotechnology | Director/Board Member | |
Vicore Pharma AB
 Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Pharmaceuticals: Major | Chairman | |
| Ascendis Pharma Growth Disorders AS | Chairman | ||
| Ascendis Pharma Bone Diseases A/S | Chairman | ||
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
 VISEN Pharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology VISEN Pharmaceuticals (Shanghai) Co., Ltd. is a Chinese pharmaceutical company that focuses on the development of products and technology for endocrine diseases. The company is based in Shanghai, China, and the CEO of the company is An Bang Lu. The company has developed a product called Long Pei, which is the first American FDA-approved growth hormone that can be released within a week to deliver growth hormone. VISEN Pharmaceuticals has also entered into a strategic cooperation agreement with Peking University Clinical Research Institute to carry out clinical research on thyroid dysfunction. | Pharmaceuticals: Major | Director/Board Member | |
| MADISON SQUARE GARDEN SPORTS CORP. | Movies/Entertainment | Comptroller/Controller/Auditor | |
Stratford Garden Development Ltd.
 Stratford Garden Development Ltd. Engineering & ConstructionIndustrial Services Part of Sphere Entertainment Co., Stratford Garden Development Ltd. is a British company that develops building projects. The company is based in London, UK and was founded in 2017. | Engineering & Construction | Director/Board Member | |
Leids Universitair Medisch Centrum
 Leids Universitair Medisch Centrum Hospital/Nursing ManagementHealth Services Leids Universitair Medisch Centrum provides medical research, patient care, training, and education. The firm offers fundamental medical and applied clinical research. The company was founded in 1996 and is headquartered in Leiden, the Netherlands. | Hospital/Nursing Management | Corporate Officer/Principal | |
Chr. Hansen A/S
 Chr. Hansen A/S Pharmaceuticals: OtherHealth Technology Chr. Hansen A/S engages in bioscience research that develops natural solutions for the food, nutritional, pharmaceutical and agricultural industries. It also develops and produces cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed. The company was founded by Christian D. A Hansen in 1874 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Other | Director/Board Member | |
| CURASIGHT A/S | Medical Specialties | Chief Operating Officer | |
| Scandinavian International Management Institute | College/University | Masters Business Admin | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistik
International
| Dänemark | 23 |
| Vereinigte Staaten | 18 |
| Niederlande | 5 |
| Schweden | 4 |
| Vereinigtes Königreich | 3 |
Sektoral
| Health Technology | 18 |
| Consumer Services | 16 |
| Commercial Services | 7 |
| Consumer Non-Durables | 2 |
| Industrial Services | 2 |
Operativ
| Director/Board Member | 224 |
| Corporate Officer/Principal | 104 |
| Independent Dir/Board Member | 58 |
| Chairman | 53 |
| Graduate Degree | 27 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Peter James Arthur Benson | 58 |
| James Healy | 50 |
| David Gill | 32 |
| Anders Gersel Pedersen | 24 |
| Michael Frank | 23 |
| Michael Wolff Jensen | 23 |
| Burt Malkiel | 22 |
| Florian Schönharting | 17 |
| Laura Hamill | 15 |
| Jens Munch-Hansen | 15 |
| Jan van de Winkel | 15 |
| Donald Lee Drakeman | 13 |
| Gérard Ber | 12 |
| Irwin Lerner | 12 |
| Hanne Damgaard Jensen | 11 |
- Börse
- Insiders
- Claus Juan Møller-San Pedro
- Unternehmensverbindungen
